5DD-13622-59227
5 vaccinations
7 coded responses
68 check-ins
6 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 631 / MO
- Registered
- 2021-01-25
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-25
Registered in v-safe
-
2021-01-25
Dose 1 — Pfizer-BioNTech
- 2021-01-25
-
2021-01-26
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-27
- 2021-01-28
- 2021-01-29
- 2021-01-30
- 2021-02-01
- 2021-02-08
-
2021-02-15
Dose 2 — Pfizer-BioNTech
- 2021-02-15
-
2021-02-16
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-17
Health check-in — days 1–6 daily, dose 2Feeling: Good · Joint pains, Muscle or body achesAdult check-in
-
2021-02-18
Health check-in — days 1–6 daily, dose 2Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-19
Health check-in — days 1–6 daily, dose 2Feeling: Good · Joint pains, Muscle or body achesAdult check-in
-
2021-02-20
Survey response — days 1–6 daily, dose 2MedDRA: Angioedema — Feeling: Good · Muscle or body achesFree text: Angioedema of lips, mild; no breathing problems or wheezing.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-21
Health check-in — days 1–6 daily, dose 2Feeling: Good · Joint pains, Muscle or body achesAdult check-in
- 2021-02-22
- 2021-03-01
- 2021-03-08
- 2021-03-15
- 2021-03-22
- 2021-03-29
-
2021-05-17
Survey response — 3 months, dose 2MedDRA: Nodule, Office visit — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Small mildly tender nodule in subcutis of left forearm developed suddenly, now decreasing in size. I see no indication that it is related to my receiving the vaccine. · Healthcare visit (other): Office visit with primary care doctor.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-17
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-16
-
2021-10-12
Dose 3 — Pfizer-BioNTech
- 2021-10-12
- 2021-10-13
- 2021-10-14
-
2021-10-15
Survey response — days 1–6 daily, dose 3MedDRA: Dermatitis — Feeling: GoodFree text: Recurrent dermatitis, localized (NOT in injection site)MedDRA releases: 2024-11 · check-in free text available
-
2021-10-16
Survey response — days 1–6 daily, dose 3MedDRA: Dermatitis, Self-medication — Feeling: GoodFree text: Recurrent localized dermatitis, responding to topical steroid ointment.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-17
Survey response — days 1–6 daily, dose 3MedDRA: Dermatitis — Feeling: GoodFree text: Localized dermatitis, resolved with topical steroid ointmentMedDRA releases: 2024-11 · check-in free text available
- 2021-10-18
- 2021-10-19
- 2021-10-26
- 2021-11-02
- 2021-11-09
- 2021-11-16
- 2021-11-23
- 2022-01-11
- 2022-04-12
-
2022-04-13
Dose 4 — Pfizer-BioNTech
-
2022-04-13
Survey response — day 0, dose 4MedDRA: No adverse event — Feeling: GoodFree text: NoneMedDRA releases: 2024-11 · check-in free text available
-
2022-04-14
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-04-15
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-04-16
- 2022-04-16
-
2022-04-17
Health check-in — days 1–6 daily, dose 4Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2022-04-18
-
2022-04-18
Call successfulNot applicable - Accidental Reporting
- 2022-04-19
- 2022-04-20
- 2022-04-27
- 2022-05-04
- 2022-05-11
- 2022-05-18
- 2022-05-25
- 2022-07-13
- 2022-10-12
-
2022-10-25
Dose 5 — Pfizer-BioNTech
- 2022-10-25
- 2022-10-26
- 2022-10-27
- 2022-10-28
- 2022-10-29
- 2022-10-30
- 2022-10-31
- 2022-11-01
- 2022-11-08
- 2022-11-15
- 2022-11-22
- 2022-11-29
- 2022-12-06
- 2023-01-24
-
2023-04-25
Survey response — 6 months, dose 5MedDRA: Meniscus injury, Physiotherapy — Feeling: Good · Get care from a doctor or other healthcare professionalMedDRA releases: 2024-11
-
2023-04-25
Report sent to call center — 6 months, dose 5Get care from a doctor or other healthcare professional1 call case(s)
- 2023-04-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-25 | Pfizer-BioNTech | |
| 2 | 2021-02-15 | Pfizer-BioNTech | |
| 3 | 2021-10-12 | Pfizer-BioNTech | No |
| 4 | 2022-04-13 | Pfizer-BioNTech | No |
| 5 | 2022-10-25 | Pfizer-BioNTech | No |
Call center
2 call center cases
1 successful · 1 unsuccessful
1 wait over 3 months for a first call
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Angioedema of lips, mild; no breathing problems or wheezing.
Release 8 — 3 months, dose 2
Symptoms: Small mildly tender nodule in subcutis of left forearm developed suddenly, now decreasing in size. I see no indication that it is related to my receiving the vaccine.
Healthcare visit (other): Office visit with primary care doctor.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Recurrent dermatitis, localized (NOT in injection site)
Systemic reaction (other): Recurrent localized dermatitis, responding to topical steroid ointment.
Systemic reaction (other): Localized dermatitis, resolved with topical steroid ointment
Release 11 — day 0, dose 4
Systemic reaction (other): None
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| HCVO | Physiotherapy | · | · | ✓ |
| SD | Meniscus injury | · | · | ✓ |
| SD | Nodule | ✓ | ✓ | ✓ |
| SRO | Angioedema | ✓ | ✓ | ✓ |
| SRO | Dermatitis | · | · | ✓ |
| SRO | No adverse event | · | · | ✓ |
| SRO | Self-medication | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release